Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Biohaven Ltd | BHVN | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
37.37 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 14.19 - 62.21 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 37.37 | USD |
Biohaven Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
3.05B | 81.58M | - | 0 | -408.17M | -5.00 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Biohaven News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BHVN Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 35.25 | 40.20 | 33.60 | 36.14 | 1,147,664 | 2.12 | 6.01% |
1 Month | 39.70 | 42.19 | 33.60 | 38.25 | 1,216,963 | -2.33 | -5.87% |
3 Months | 47.20 | 62.21 | 33.60 | 48.23 | 1,440,741 | -9.83 | -20.83% |
6 Months | 30.88 | 62.21 | 29.11 | 45.02 | 1,236,451 | 6.49 | 21.02% |
1 Year | 14.19 | 62.21 | 14.19 | 34.24 | 1,205,505 | 23.18 | 163.35% |
3 Years | 72.49 | 152.56 | 7.10 | 64.11 | 1,057,823 | -35.12 | -48.45% |
5 Years | 60.81 | 152.56 | 7.10 | 61.94 | 928,380 | -23.44 | -38.55% |
Biohaven Description
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. |